IS4532A - Notkun Melatóníns til meðferðar lyfjafíkla - Google Patents

Notkun Melatóníns til meðferðar lyfjafíkla

Info

Publication number: IS4532A
Authority: IS; Iceland
Prior art keywords: melatonin; drug addicts; treat drug; treat; addicts
Prior art date: 1995-02-01

Application number

IS4532A

Other languages

English (en)

Other versions

IS1980B (is

Inventor

Zisapel Nava

Original Assignee

Neurim Pharmaceuticals (1991) Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1997-07-25

Publication date

1997-07-25

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1997-07-25 Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.

1997-07-25 Publication of IS4532A publication Critical patent/IS4532A/is

2005-01-14 Publication of IS1980B publication Critical patent/IS1980B/is

Links

YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
229960003987 melatonin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS4532A 1995-02-01 1997-07-25 Notkun Melatóníns til meðferðar lyfjafíkla IS1980B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number	Publication Date
IS4532A true IS4532A (is)	1997-07-25
IS1980B IS1980B (is)	2005-01-14

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4532A IS1980B (is)	1995-02-01	1997-07-25	Notkun Melatóníns til meðferðar lyfjafíkla

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (is)
CN (1)	CN1083263C (is)
AT (1)	AT408188B (is)
AU (1)	AU695366B2 (is)
BG (1)	BG62876B1 (is)
BR (1)	BR9607169A (is)
CZ (1)	CZ291349B6 (is)
DK (1)	DK176081B1 (is)
EE (1)	EE03384B1 (is)
FI (1)	FI119586B (is)
IS (1)	IS1980B (is)
LU (1)	LU90118B1 (is)
LV (1)	LV11940B (is)
MD (1)	MD1716C2 (is)
NO (1)	NO312814B1 (is)
NZ (1)	NZ298878A (is)
PL (1)	PL183148B1 (is)
SI (1)	SI9620022A (is)
SK (1)	SK284521B6 (is)
TR (1)	TR199700723T1 (is)
TW (1)	TW483757B (is)
WO (1)	WO1996023496A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL150190A0 (en)	2000-01-05	2002-12-01	Neurim Pharma 1991	Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Insomnia treatment
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
IL330095A (en)	2012-01-26	2026-08-01	Vanda Pharmaceuticals Inc	Tesimalta for use in the treatment of asynchronous circadian rhythm of cortisol
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
IL266159B2 (en)	2012-12-18	2024-07-01	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
DK3337462T3 (da) *	2016-10-31	2020-10-12	Neurim Pharma 1991	Melatonin-minitabletter og fremgangsmåde til fremstilling heraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229490T2 (de) *	1991-05-09	2000-02-17	Neurim Pharmaceuticals (1991) Ltd., Tel Aviv	Melatonin enthaltende Arzneimittel
IT1251544B (it) *	1991-05-13	1995-05-17	Gabriele Biella	Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

1996
- 1996-01-29 MD MD97-0254A patent/MD1716C2/ro not_active IP Right Cessation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/xx unknown
- 1996-01-29 BR BR9607169A patent/BR9607169A/pt not_active Application Discontinuation
- 1996-01-29 CN CN96191750A patent/CN1083263C/zh not_active Expired - Lifetime
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/cs not_active IP Right Cessation
- 1996-01-29 NZ NZ298878A patent/NZ298878A/xx not_active IP Right Cessation
- 1996-01-29 EE EE9700166A patent/EE03384B1/xx not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 PL PL96321630A patent/PL183148B1/pl unknown
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 JP JP52338596A patent/JP4516159B2/ja not_active Expired - Lifetime
- 1996-01-29 SI SI9620022A patent/SI9620022A/sl not_active IP Right Cessation
- 1996-01-29 SK SK1030-97A patent/SK284521B6/sk unknown
- 1996-01-29 AT AT0901396A patent/AT408188B/de not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/zh not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/is unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/da not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/bg unknown
- 1997-07-31 NO NO19973531A patent/NO312814B1/no not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/fi not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/fr active

Also Published As

Publication number	Publication date
PL183148B1 (pl)	2002-05-31
CZ240597A3 (cs)	1998-01-14
BR9607169A (pt)	1997-11-11
MD1716C2 (ro)	2002-02-28
PL321630A1 (en)	1997-12-08
EE9700166A (et)	1998-02-16
ATA901396A (de)	2001-02-15
JP4516159B2 (ja)	2010-08-04
SK284521B6 (sk)	2005-05-05
FI973185A0 (fi)	1997-07-31
MD970254A (en)	1999-05-31
SI9620022A (sl)	1998-10-31
TW483757B (en)	2002-04-21
TR199700723T1 (xx)	1998-02-21
EE03384B1 (et)	2001-04-16
NZ298878A (en)	1999-05-28
IS1980B (is)	2005-01-14
DK89697A (da)	1997-07-30
MX9705856A (es)	1998-07-31
AU4457496A (en)	1996-08-21
FI119586B (fi)	2009-01-15
SK103097A3 (en)	1998-01-14
JPH10513177A (ja)	1998-12-15
CN1083263C (zh)	2002-04-24
BG101803A (en)	1998-04-30
NO973531L (no)	1997-09-30
WO1996023496A1 (en)	1996-08-08
CZ291349B6 (cs)	2003-02-12
CN1172431A (zh)	1998-02-04
LV11940A (lv)	1998-01-20
AT408188B (de)	2001-09-25
MD1716B2 (en)	2001-08-31
LV11940B (en)	1998-05-20
FI973185L (fi)	1997-09-30
DK176081B1 (da)	2006-04-18
AU695366B2 (en)	1998-08-13
NO973531D0 (no)	1997-07-31
NO312814B1 (no)	2002-07-08
BG62876B1 (bg)	2000-10-31
LU90118B1 (fr)	1997-11-13

Publication	Publication Date	Title
PT851855E (pt)	2002-10-31	Derivados acilados de melatonina e de analogos uteis como medicamentos
DE69633333D1 (de)	2004-10-14	Diphosphonatderivate von therapeutischen substanzen
NO20001962D0 (no)	2000-04-14	Terapeutisk anvendelse av kinolinderivater
IT1283046B1 (it)	1998-04-07	Procedimento per riconoscere mancate combustioni
FI972681A0 (fi)	1997-06-19	Kynsien sientenvastainen käsittely
DE69530004D1 (de)	2003-04-24	Transdermale verabreichung von apomorphin
NO973928L (no)	1997-10-28	Behandling av oljebrönn
LV11895A (lv)	1997-12-20	4-benzoilpirazola atvasinajumi un to pielietojums par herbicidiem
NO982172D0 (no)	1998-05-13	Anvendelse av epinastin for behandling av smerter
NO20001479L (no)	2000-03-22	Behandling av atferdsforstyrrelse
ID18679A (id)	1998-04-30	Penggunaan terapi lanjutan
IT1283827B1 (it)	1998-04-30	Procedimento per riconoscere mancate combustioni
DE59500266D1 (de)	1997-07-03	Transdermales therapeutisches System zur Applikation von Naloxon
DE69620691D1 (de)	2002-05-23	Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69512760D1 (de)	1999-11-18	Verwendung von Melatonin zur Behandlung von Patienten die an Drogenabhängigkeit leiden
LV11971A (lv)	1998-02-20	Pirolidinhidroksamskabes atvasinajumi un to iegusanas panemiens
NO975718L (no)	1998-02-04	Behandling av insulinresistens
IS1980B (is)	2005-01-14	Notkun Melatóníns til meðferðar lyfjafíkla
IS4528A (is)	1997-07-21	Bísýklískar afleiður ísóþíóþvagefnis nothæfar viðlæknismeðferð
FI973023L (fi)	1997-07-16	Liikakasvusairauksien yhdistetty terapeuttinen hoito
NO995231D0 (no)	1999-10-26	Terapeutisk behandling av hudlidelser
FI971527A7 (fi)	1997-04-11	Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
FI964619A0 (fi)	1996-11-19	Epilepsialääkkeiden iholle annostelu
FR2757059B1 (fr)	1999-01-29	Nouvelle application therapeutique des derives du pyrrole
NO20015738D0 (no)	2001-11-26	Terapeutisk bruk av melatonin